Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26686957

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Feb 27
First author
Margolese RG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Feb 27;387(10021):819-21. doi: 10.1016/S0140-6736(15)01219-2.
    note
    Source null
    related pmid
    26686312
    relationship
    Comment in

Authors and identifiers

  1. name
    Margolese RG
    type
    Author
  2. name
    Cecchini RS
    type
    Author
  3. name
    Julian TB
    type
    Author
  4. name
    Ganz PA
    type
    Author
  5. name
    Costantino JP
    type
    Author
  6. name
    Vallow LA
    type
    Author
  7. name
    Albain KS
    type
    Author
  8. name
    Whitworth PW
    type
    Author
  9. name
    Cianfrocca ME
    type
    Author
  10. name
    Brufsky AM
    type
    Author
  11. name
    Gross HM
    type
    Author
  12. name
    Soori GS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Margolese RG
    type
    Author
  2. name
    Cecchini RS
    type
    Author
  3. name
    Julian TB
    type
    Author
  4. name
    Ganz PA
    type
    Author
  5. name
    Costantino JP
    type
    Author
  6. name
    Vallow LA
    type
    Author
  7. name
    Albain KS
    type
    Author
  8. name
    Whitworth PW
    type
    Author
  9. name
    Cianfrocca ME
    type
    Author
  10. name
    Brufsky AM
    type
    Author
  11. name
    Gross HM
    type
    Author
  12. name
    Soori GS
    type
    Author
bibliography ids
  1. nci-bib-5b7ac523cf8dd1a4f1f6c87a
book metadata
content sha256
df69237bc9f491a024defe410e892e6374e975a3574375ae4b3c69d1b6b3191f
document type
citation
dois
  1. 10.1016/S0140-6736(15)01168-X
electronic publication date
display
2015 Dec 11
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26686957
immutable id
pubmed:26686957@df69237bc9f491a024defe410e892e6374e975a3574375ae4b3c69d1b6b3191f
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10021
name
Lancet (London, England)
nlm unique id
2985213R
pages
849-56
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Feb 27;387(10021):819-21. doi: 10.1016/S0140-6736(15)01219-2.
    note
    Source null
    related pmid
    26686312
    relationship
    Comment in
outcomes validated
false
pmid
26686957
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
40755421813bb958593c9e179fb04ab1454e6c40c4a1c8310179dbe4c5f1bbe4
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Feb 27
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26686957/
title
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.

Preserved source evidence · Not medical advice